Rebecca Ann Previs, MD
Rebecca Ann Previs, MD
Dr.
The University of Texas MD Anderson Cancer Center
7676 Phoenix Drive
Apt 1106
Houston,
TX
USA
77030
Papers:
46
Homologous recombination deficiency in uterine cancer
128
Disease stabilization vs. response after bevacizumab treatment in recurrent ovarian cancer: how do we determine clinical efficacy?
134
The FAK of uterine cancer: PTEN expression predicts response of uterine cancer to focal adhesion kinase inhibition
135
Molecular predictors of response to EphA2 targeted therapy in uterine cancer
155
Fuel for the fire: connecting genomics with metabolomics in ovarian cancer
159
Role of increased n-acetylaspartate levels in epithelial ovarian cancer